WO2022150023A1 - Wound healing and burn cream with camellia sinensis (white tea) essential - Google Patents
Wound healing and burn cream with camellia sinensis (white tea) essential Download PDFInfo
- Publication number
- WO2022150023A1 WO2022150023A1 PCT/TR2021/050457 TR2021050457W WO2022150023A1 WO 2022150023 A1 WO2022150023 A1 WO 2022150023A1 TR 2021050457 W TR2021050457 W TR 2021050457W WO 2022150023 A1 WO2022150023 A1 WO 2022150023A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- weight
- white tea
- skin
- fatty acids
- ppm
- Prior art date
Links
- 239000006071 cream Substances 0.000 title claims abstract description 49
- 235000020334 white tea Nutrition 0.000 title claims abstract description 34
- 244000269722 Thea sinensis Species 0.000 title claims abstract description 14
- 230000029663 wound healing Effects 0.000 title claims abstract description 13
- 235000006468 Thea sinensis Nutrition 0.000 title claims abstract description 9
- 239000000284 extract Substances 0.000 claims abstract description 28
- 102000008186 Collagen Human genes 0.000 claims abstract description 19
- 108010035532 Collagen Proteins 0.000 claims abstract description 19
- 229920001436 collagen Polymers 0.000 claims abstract description 19
- 230000035876 healing Effects 0.000 claims abstract description 15
- 230000006907 apoptotic process Effects 0.000 claims abstract description 12
- 230000006378 damage Effects 0.000 claims abstract description 12
- 230000015572 biosynthetic process Effects 0.000 claims abstract description 11
- 229910052760 oxygen Inorganic materials 0.000 claims abstract description 10
- 239000001301 oxygen Substances 0.000 claims abstract description 10
- 206010040882 skin lesion Diseases 0.000 claims abstract description 10
- 231100000444 skin lesion Toxicity 0.000 claims abstract description 10
- 210000002919 epithelial cell Anatomy 0.000 claims abstract description 8
- 238000004519 manufacturing process Methods 0.000 claims abstract description 7
- 238000003786 synthesis reaction Methods 0.000 claims abstract description 7
- 230000037303 wrinkles Effects 0.000 claims abstract description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 16
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 claims description 14
- 235000005487 catechin Nutrition 0.000 claims description 14
- 229930003427 Vitamin E Natural products 0.000 claims description 8
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 8
- 239000012188 paraffin wax Substances 0.000 claims description 8
- 235000019165 vitamin E Nutrition 0.000 claims description 8
- 229940046009 vitamin E Drugs 0.000 claims description 8
- 239000011709 vitamin E Substances 0.000 claims description 8
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 claims description 7
- 229950001002 cianidanol Drugs 0.000 claims description 7
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 claims description 7
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 claims description 7
- 150000004671 saturated fatty acids Chemical class 0.000 claims description 7
- 235000003441 saturated fatty acids Nutrition 0.000 claims description 7
- 235000021281 monounsaturated fatty acids Nutrition 0.000 claims description 6
- PFTAWBLQPZVEMU-ZFWWWQNUSA-N (+)-epicatechin Natural products C1([C@@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-ZFWWWQNUSA-N 0.000 claims description 5
- PFTAWBLQPZVEMU-UKRRQHHQSA-N (-)-epicatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-UKRRQHHQSA-N 0.000 claims description 5
- 239000010949 copper Substances 0.000 claims description 5
- LPTRNLNOHUVQMS-UHFFFAOYSA-N epicatechin Natural products Cc1cc(O)cc2OC(C(O)Cc12)c1ccc(O)c(O)c1 LPTRNLNOHUVQMS-UHFFFAOYSA-N 0.000 claims description 5
- 235000012734 epicatechin Nutrition 0.000 claims description 5
- 239000011572 manganese Substances 0.000 claims description 5
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 claims description 4
- LSHVYAFMTMFKBA-TZIWHRDSSA-N (-)-epicatechin-3-O-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=CC=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 LSHVYAFMTMFKBA-TZIWHRDSSA-N 0.000 claims description 4
- LSHVYAFMTMFKBA-UHFFFAOYSA-N ECG Natural products C=1C=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 LSHVYAFMTMFKBA-UHFFFAOYSA-N 0.000 claims description 4
- WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 claims description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 4
- 239000011575 calcium Substances 0.000 claims description 4
- 229940030275 epigallocatechin gallate Drugs 0.000 claims description 4
- 239000011777 magnesium Substances 0.000 claims description 4
- 150000008442 polyphenolic compounds Chemical class 0.000 claims description 4
- 235000013824 polyphenols Nutrition 0.000 claims description 4
- 239000011734 sodium Substances 0.000 claims description 4
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 3
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 claims description 3
- 229910052782 aluminium Inorganic materials 0.000 claims description 3
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims description 3
- 230000001153 anti-wrinkle effect Effects 0.000 claims description 3
- 229910052802 copper Inorganic materials 0.000 claims description 3
- 229910052748 manganese Inorganic materials 0.000 claims description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 2
- 229910052791 calcium Inorganic materials 0.000 claims description 2
- 229940074391 gallic acid Drugs 0.000 claims description 2
- 235000004515 gallic acid Nutrition 0.000 claims description 2
- 229910052749 magnesium Inorganic materials 0.000 claims description 2
- 239000011591 potassium Substances 0.000 claims description 2
- 229910052700 potassium Inorganic materials 0.000 claims description 2
- 229910052708 sodium Inorganic materials 0.000 claims description 2
- JBQYATWDVHIOAR-UHFFFAOYSA-N tellanylidenegermanium Chemical compound [Te]=[Ge] JBQYATWDVHIOAR-UHFFFAOYSA-N 0.000 claims description 2
- 208000027418 Wounds and injury Diseases 0.000 abstract description 17
- 206010052428 Wound Diseases 0.000 abstract description 15
- 230000001965 increasing effect Effects 0.000 abstract description 11
- 230000003902 lesion Effects 0.000 abstract description 5
- 210000003491 skin Anatomy 0.000 description 34
- 238000011282 treatment Methods 0.000 description 24
- 230000000694 effects Effects 0.000 description 12
- 210000004027 cell Anatomy 0.000 description 10
- 210000002615 epidermis Anatomy 0.000 description 9
- 108010081750 Reticulin Proteins 0.000 description 8
- 210000002808 connective tissue Anatomy 0.000 description 8
- 210000004207 dermis Anatomy 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- -1 oxygen radicals Chemical class 0.000 description 8
- 229920001296 polysiloxane Polymers 0.000 description 8
- 150000001765 catechin Chemical class 0.000 description 7
- 210000004443 dendritic cell Anatomy 0.000 description 7
- 230000000451 tissue damage Effects 0.000 description 7
- 231100000827 tissue damage Toxicity 0.000 description 7
- 239000004615 ingredient Substances 0.000 description 6
- 230000007246 mechanism Effects 0.000 description 6
- 231100000075 skin burn Toxicity 0.000 description 6
- 206010061218 Inflammation Diseases 0.000 description 5
- 108010057466 NF-kappa B Proteins 0.000 description 5
- 102000003945 NF-kappa B Human genes 0.000 description 5
- 230000004913 activation Effects 0.000 description 5
- 229930003935 flavonoid Natural products 0.000 description 5
- 235000017173 flavonoids Nutrition 0.000 description 5
- 150000002215 flavonoids Chemical class 0.000 description 5
- 239000000499 gel Substances 0.000 description 5
- 235000009569 green tea Nutrition 0.000 description 5
- 230000004054 inflammatory process Effects 0.000 description 5
- 230000036542 oxidative stress Effects 0.000 description 5
- 230000000699 topical effect Effects 0.000 description 5
- 108020004414 DNA Proteins 0.000 description 4
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 239000000090 biomarker Substances 0.000 description 4
- 210000000981 epithelium Anatomy 0.000 description 4
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 4
- 208000014674 injury Diseases 0.000 description 4
- 210000003205 muscle Anatomy 0.000 description 4
- 230000001681 protective effect Effects 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 231100000241 scar Toxicity 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- HCAJQHYUCKICQH-VPENINKCSA-N 8-Oxo-7,8-dihydro-2'-deoxyguanosine Chemical compound C1=2NC(N)=NC(=O)C=2NC(=O)N1[C@H]1C[C@H](O)[C@@H](CO)O1 HCAJQHYUCKICQH-VPENINKCSA-N 0.000 description 3
- 108090000695 Cytokines Proteins 0.000 description 3
- 102000004127 Cytokines Human genes 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- 230000002421 anti-septic effect Effects 0.000 description 3
- 108700000707 bcl-2-Associated X Proteins 0.000 description 3
- 102000055102 bcl-2-Associated X Human genes 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 210000003470 mitochondria Anatomy 0.000 description 3
- 230000002438 mitochondrial effect Effects 0.000 description 3
- 230000008092 positive effect Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 150000003254 radicals Chemical class 0.000 description 3
- 210000000438 stratum basale Anatomy 0.000 description 3
- 238000007920 subcutaneous administration Methods 0.000 description 3
- 108010089941 Apoptosomes Proteins 0.000 description 2
- 108090000397 Caspase 3 Proteins 0.000 description 2
- 102100029855 Caspase-3 Human genes 0.000 description 2
- 102000011727 Caspases Human genes 0.000 description 2
- 108010076667 Caspases Proteins 0.000 description 2
- 208000032544 Cicatrix Diseases 0.000 description 2
- 102000018832 Cytochromes Human genes 0.000 description 2
- 108010052832 Cytochromes Proteins 0.000 description 2
- WSMYVTOQOOLQHP-UHFFFAOYSA-N Malondialdehyde Chemical compound O=CCC=O WSMYVTOQOOLQHP-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 206010053615 Thermal burn Diseases 0.000 description 2
- 102000040945 Transcription factor Human genes 0.000 description 2
- 108091023040 Transcription factor Proteins 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 230000033115 angiogenesis Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 125000004403 catechin group Chemical group 0.000 description 2
- 230000030833 cell death Effects 0.000 description 2
- 210000000805 cytoplasm Anatomy 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000005611 electricity Effects 0.000 description 2
- 210000004920 epithelial cell of skin Anatomy 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 229960003180 glutathione Drugs 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 229910001385 heavy metal Inorganic materials 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 210000002510 keratinocyte Anatomy 0.000 description 2
- 229940118019 malondialdehyde Drugs 0.000 description 2
- 230000004065 mitochondrial dysfunction Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000000770 proinflammatory effect Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 230000037387 scars Effects 0.000 description 2
- 229960003600 silver sulfadiazine Drugs 0.000 description 2
- UEJSSZHHYBHCEL-UHFFFAOYSA-N silver(1+) sulfadiazinate Chemical compound [Ag+].C1=CC(N)=CC=C1S(=O)(=O)[N-]C1=NC=CC=N1 UEJSSZHHYBHCEL-UHFFFAOYSA-N 0.000 description 2
- 238000011477 surgical intervention Methods 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 230000008733 trauma Effects 0.000 description 2
- 239000011787 zinc oxide Substances 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 241000931515 Acer palmatum Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 244000291564 Allium cepa Species 0.000 description 1
- 235000005255 Allium cepa Nutrition 0.000 description 1
- 244000144927 Aloe barbadensis Species 0.000 description 1
- 235000002961 Aloe barbadensis Nutrition 0.000 description 1
- 102000010565 Apoptosis Regulatory Proteins Human genes 0.000 description 1
- 108010063104 Apoptosis Regulatory Proteins Proteins 0.000 description 1
- 102100021569 Apoptosis regulator Bcl-2 Human genes 0.000 description 1
- 208000003950 B-cell lymphoma Diseases 0.000 description 1
- 108010001478 Bacitracin Proteins 0.000 description 1
- 206010006797 Burns first degree Diseases 0.000 description 1
- 206010006802 Burns second degree Diseases 0.000 description 1
- 206010006803 Burns third degree Diseases 0.000 description 1
- 101001082567 Caenorhabditis elegans Hypoxia-inducible factor 1 Proteins 0.000 description 1
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- 102000004039 Caspase-9 Human genes 0.000 description 1
- 108090000566 Caspase-9 Proteins 0.000 description 1
- 208000009043 Chemical Burns Diseases 0.000 description 1
- 230000005778 DNA damage Effects 0.000 description 1
- 231100000277 DNA damage Toxicity 0.000 description 1
- 230000005971 DNA damage repair Effects 0.000 description 1
- 102000007989 Effector Caspases Human genes 0.000 description 1
- 108010089510 Effector Caspases Proteins 0.000 description 1
- 206010069808 Electrical burn Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 102000006587 Glutathione peroxidase Human genes 0.000 description 1
- 108700016172 Glutathione peroxidases Proteins 0.000 description 1
- 101000971171 Homo sapiens Apoptosis regulator Bcl-2 Proteins 0.000 description 1
- 101000617130 Homo sapiens Stromal cell-derived factor 1 Proteins 0.000 description 1
- 102000008070 Interferon-gamma Human genes 0.000 description 1
- 108010074328 Interferon-gamma Proteins 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 108020005196 Mitochondrial DNA Proteins 0.000 description 1
- 108091093105 Nuclear DNA Proteins 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- 229940123973 Oxygen scavenger Drugs 0.000 description 1
- 235000014676 Phragmites communis Nutrition 0.000 description 1
- 206010063562 Radiation skin injury Diseases 0.000 description 1
- 206010039020 Rhabdomyolysis Diseases 0.000 description 1
- 240000000513 Santalum album Species 0.000 description 1
- 235000008632 Santalum album Nutrition 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- 206010040829 Skin discolouration Diseases 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 208000013200 Stress disease Diseases 0.000 description 1
- 102100021669 Stromal cell-derived factor 1 Human genes 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
- 102100040247 Tumor necrosis factor Human genes 0.000 description 1
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 1
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 210000001789 adipocyte Anatomy 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- 230000001195 anabolic effect Effects 0.000 description 1
- 230000002491 angiogenic effect Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000001640 apoptogenic effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 229960003071 bacitracin Drugs 0.000 description 1
- 229930184125 bacitracin Natural products 0.000 description 1
- CLKOFPXJLQSYAH-ABRJDSQDSA-N bacitracin A Chemical compound C1SC([C@@H](N)[C@@H](C)CC)=N[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]1C(=O)N[C@H](CCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2N=CNC=2)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)NCCCC1 CLKOFPXJLQSYAH-ABRJDSQDSA-N 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 239000006161 blood agar Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 230000037182 bone density Effects 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 230000022131 cell cycle Effects 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000007330 chocolate agar Substances 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 206010010121 compartment syndrome Diseases 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 229960001334 corticosteroids Drugs 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 238000001804 debridement Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000001909 effect on DNA Effects 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 210000002472 endoplasmic reticulum Anatomy 0.000 description 1
- 230000037149 energy metabolism Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 238000002637 fluid replacement therapy Methods 0.000 description 1
- 235000021588 free fatty acids Nutrition 0.000 description 1
- 230000037313 granulation tissue formation Effects 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 239000012676 herbal extract Substances 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 229960002751 imiquimod Drugs 0.000 description 1
- DOUYETYNHWVLEO-UHFFFAOYSA-N imiquimod Chemical compound C1=CC=CC2=C3N(CC(C)C)C=NC3=C(N)N=C21 DOUYETYNHWVLEO-UHFFFAOYSA-N 0.000 description 1
- 230000006882 induction of apoptosis Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229960003130 interferon gamma Drugs 0.000 description 1
- 229940047124 interferons Drugs 0.000 description 1
- 230000034727 intrinsic apoptotic signaling pathway Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 230000029774 keratinocyte migration Effects 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000012009 microbiological test Methods 0.000 description 1
- 210000001700 mitochondrial membrane Anatomy 0.000 description 1
- 230000004769 mitochondrial stress Effects 0.000 description 1
- 230000000394 mitotic effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 210000005087 mononuclear cell Anatomy 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 238000012536 packaging technology Methods 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000008823 permeabilization Effects 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 235000020004 porter Nutrition 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000004224 protection Effects 0.000 description 1
- 239000003223 protective agent Substances 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 230000017854 proteolysis Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 238000012502 risk assessment Methods 0.000 description 1
- 235000021003 saturated fats Nutrition 0.000 description 1
- 230000037390 scarring Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 229920000260 silastic Polymers 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 230000037370 skin discoloration Effects 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000036575 thermal burns Effects 0.000 description 1
- 230000009772 tissue formation Effects 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/34—Copper; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/31—Hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/678—Tocopherol, i.e. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
Definitions
- the present invention relates to a wound healing and burn cream containing Camellia sinensis (white tea) extract that helps healing of skin lesions, particularly burn lesions and wounds.
- Said cream increases the synthesis of collagen fibrils by supporting the epithelial cells in the skin, ensures healing of skin lesions after burns or physical damage by reducing apoptosis and suppressing the production of free oxygen radicals.
- the inventive cream prevents skin wrinkles by increasing the number of collagen fibrils.
- Burn is a type of injury that results in losing the integrity of the skin due to high heat, extreme cold, electricity, friction, radiation or chemicals. Burns may occur due to many environmental factors. It may occur due to too much exposure to the sun, electric shocks, boiling water, fire or many other similar external factors. Today, most of the burns are caused by home accidents or the sun. Burns may occur in various forms such as; thermal burns (flame, steam burns), chemical burns (by contact with acid or base products), radiation burns (sun rays, tanning beds, etc.), electrical burns. Burn symptoms vary based on the severity of the burn. There may be peeling, skin discoloration and pain. The most common complication pertaining to burns is infection.
- Electricity burns cause compartment syndrome (edema in the area where the muscles gathered) and rhabdomyolysis (sudden and rapid damage to the muscle tissues in the body for any reason) due to damage to the muscles. It may cause a decrease in bone density and loss of muscle mass based on the degree of burn.
- the patient may experience stress disorder after trauma by being psychologically affected in major burns. There may be disturbing scars based on the degree and size of the burn. Sunburns may lead to skin cancer. Burns are evaluated in different severities as first, second and third degrees. Treatment is determined based on the degree of burn. The first and second degree burns heal within 2-3 weeks without leaving a scar with drug treatment. If more than 2/3 of the dermis are affected, scars and loss of function are seen.
- the skin is the largest organ of the human body responsible for the protection, temperature regulation and sensitivity of the organism and consists of three layers: epidermis, dermis and hypodermis.
- the epidermis is the outermost layer of the skin and consists mostly of cells that are called keratinocytes.
- the dermis is the second layer of skin under the epidermal layer.
- the main cells in the dermis are fibroblasts and constitute the extracellular support matrix tissue of the dermis.
- Hypodermis is the lowest layer of the skin and consists of cells that are called lipocytes.
- Skin healing is a systemic process that comprises; hemostasis (coagulation), inflammation (mononuclear cell infiltration), proliferation (epithelization, fibroplasia, angiogenesis and granulation tissue formation) and maturation (collagen accumulation or tissue formation), respectively, in the wound area (Hermans 2005, Zhu and Gao 2008, Stallings and Lupo 2009, Lorenti 2012, Atat et al. 2015, Anthonissen et al. 2016, Shpichka et al.
- the expected treatment of creams in skin lesions such as skin burns that are caused by contact with physical and chemical substances is to increase the number of collagen and reticular fibrils under the skin and to assist in skin healing with its positive effects on keratonocytes and dendritic cells in the skin epithelium (Hermans 2005, Li-Tsang et al. 2006, Sakallioglu et al. 2006, Wolfram et al. 2009, Zhang et al. 2010, Lorenti 2012, Degeorge et al. 2014, Wasiak and Cleland 2015, Vinish et al. 2016, Bae et al. 2017).
- Angiogenesis is induced by hypoxia-induced factor 1 and angiogenic cytokines such as VEGF and CXCL12 during healing of the burn (Wilgus et al. 2008, Wolfram et al. 2009, Domingo et al. 2010, Zhang etal. 2010, Atat et al. 2015, Li et al. 2016, Shpichka et al. 2019). It was reported in recent studies that epigalactocatechin gallate (EGCG) has positive effects on dendritic cells in the epidermis layer (Jeong et al. 2007, Yoneyama et al. 2008).
- EGCG epigalactocatechin gallate
- epigalactocatechin gallate EGCG
- epigalactocatechin gallate ECG
- epigalactocatechin ECC
- flavonoids activate keratonocytes in the findings. It was reported that the high amount of EGCG, catechins (EG) and flavonoids in white tea have very positive effects on keratonocytes and dendritic cells in the epidermis layer of the skin, and in addition to its properties rarely found in other protective agents, it also increases the number of collagen and reticular fibrils in the dermis and hypodermis layers of the skin (Hsu et al. 2003, Hsu 2005, Yoneyama et al. 2008, Li et al. 2016).
- NFk-B nuclear factor-kappa B
- TNF-a TNF-a
- I L-1 b proinflammatory cytokines
- Intrinsic apoptosis is a cell death centered in mitochondria caused by mitochondrial outer membrane permeabilization-mediated apoptosome formation, activation of caspase-9 and subsequent activation of effector caspases (Thornberry 1998, Yang et al. 1998, Reed 2000, Galluzzi et al. 2016).
- Activation of caspase-3 plays an extremely important role in apoptosis among applying caspases and is accepted as a terminal event prior to cell death.
- Bcl-2 B-cell lymphoma 2 prevents the effects of Bax (BCL2-associated X protein), which is a proapoptotic protein by being located in the outer membrane of mitochondria, maintains mitochondrial membrane integrity and supports cell survival.
- Bax increases mitochondrial permeability by causing both cytochrome C and SOR to be discharged from the mitochondria to the cytoplasm under oxidative stress conditions.
- Cytochrome C forms an apoptosome that activates caspase-3, a key regulator in the execution of apoptosis by interacting with apoptotic proteactivation factor 1 (Apaf-1) in the cytoplasm (Zhou et al. n.d., Ohta et al. 1997, Yu and Little 1998, Snigdha et al. 2012, Brentnall et al. 2013, Lopez-Furelos et al. 2016).
- Apaf-1 apoptotic proteactivation factor 1
- the present invention describes a wound healing and burn cream containing white tea ("Camellia sinensis”), which has a protective effect on tissue damage. While said cream heals skin lesions after burns or physical damage, it also prevents skin wrinkles by increasing the number of collagen fibrils.
- An aim of the invention is to develop a wound and burn cream that provides effective healing.
- the inventive cream provides an effective treatment for skin tissue damage and especially in the treatment of burns due to its healing effect on the epidermis in addition to the connective tissue.
- Another aim of the invention is to provide a wound healing and burn cream that does not have a negative effect on the human health due to its natural content.
- the white tea extract contained in the content of the invention provides a protective effect on tissue damage formed as a result of burn. It does not cause any side effects, not only it is a natural ingredient, but also it provides an environmentally friendly content.
- Another aim of the invention is to provide a cream with an anti-wrinkle formulation besides preventing skin lesions.
- Said wound and burn cream also has an anti-wrinkle effect in addition to healing wounds and burns. This effect is ensured by increasing the number of collagen fibrils in the connective tissue of the ingredients in the cream.
- Another aim of the invention is to develop a cost efficient method for wound and burn treatment.
- the treatment of skin tissue damage is effectively provided, it reduces treatment costs by replacing burn intensive care and skin transplantation, which is a troublesome and expensive method.
- IFN-y interferon-gamma
- the present invention is a wound healing and burn cream that increases the synthesis of collagen fibrils by supporting the epithelial cells in the skin, ensures healing of skin lesions after burns or physical damage by reducing apoptosis and suppressing the production of free oxygen radicals.
- Cream with white tea extract contains; white tea ( Camellia sinensis) extract, saturated fatty acids, monosaturated and polyunsaturated fatty acids, vitamin E and paraffin.
- Said wound healing and burn cream contains the following; 8-12% of white tea extract by weight, 8-12% of saturated fatty acids by weight, 32-36% of monounsaturated fatty acids by weight, 3-7% of polyunsaturated fatty acids by weight, 3-7% of vitamin E by weight and 33- 37% of paraffin by weight.
- said wound healing and burn cream contains the following; 10.14% of white tea extract, by weight 10.48% of saturated fatty acids by weight, 34% of monounsaturated fatty acids by weight, 5.38% of polyunsaturated fatty acids by weight, 5% of vitamin E by weight and 35% of paraffin by weight (Table 1).
- the white tea extract used in said cream contains 35-39% of polyphenol by weight, preferably 37.05% of polyphenol in total, but no cellulose.
- the white tea extract used in the country is preferably used as catechin contains; 2.89% of gallic acid by weight, 0.96% of catechin (C) by weight, 5.31% of epicatechin (EC) by weight, 74.61% of epigallocatechin gallate (EGCG) by weight and 16.23% of epicatechin gallate (ECG) by weight (Table 2).
- This white tea extract also contains; 0.064 ppm copper (Cu), 0.112 ppm iron (Fe), 0.65 ppm zinc (Zn), 2.47 ppm sodium (Na), 492 ppm potassium (K), 14.51 ppm calcium (Ca), 311 ppm manganese (Mn), 69.3 ppm magnesium (Mg,), 1.59 ppm aluminum (Al) (Table 3).
- Table 1 Content analysis of wound healing and burn cream ( 100 mg by weight).
- the polyphenols, saturated fatty acids, monounsaturated fatty acids, polyunsaturated fatty acids and vitamin E contained in the cream have the effect of reducing free oxygen radicals by reducing the apoptosis in the epithelial cells of the skin.
- the iron, copper and manganese contained in white tea extract increase the number of collagen and reticular fibrils in the subcutaneous connective tissue.
- the aluminum content included in the ingredient exhibits an antiseptic effect; while zinc has an antiseptic effect, it also strengthens the connection between skin epithelial cells. Paraffin content also provides an antiseptic effect to the cream.
- Said cream contains 2-3% catechin in total.
- Catechins are natural antioxidants that assist in preventing the cell damage. Catechin can reduce the formation of free radicals in the body and protect cells and molecules against radical damage. It is known that free radicals play a role in accelerating the aging process.
- EGCG Epigallocatechin Gallate
- EGC Epigallocatechin Gallate
- EGCG and EGC from these catechins from white tea extract increase the number of the productive layer (stratum germinativum) in the skin epithelium, increase the number of collagen and reticular fibrils in subcutaneous connective tissue, inhibits the antigen presenting mechanism of dendritic cells.
- these catechins have the effect of reducing free oxygen radicals by reducing apoptosis in epithelial cells in the skin.
- the most suitable extract was obtained by analyzing the brewed, dried, wet extracts and their catechin groups and mineral contents by HPLC analysis (Tables 1-4) so as to examine the protective and therapeutic effects of white tea extract against physiological aging or physical and chemical trauma, skin clinical correlations due to skin burns.
- Burn cream prototype is obtained with its ingredients by mixing the obtained extract, white tea extract previously obtained with natural methods with the cream that is previously designed and contains alkali esters (72%), free fatty acids (14%), hydrocarbons (11%), free alcohols (1%), oleic acid, paraffin, stearic acid, vitamin E and neutral saturated fat (with a ratio of 3% white tea extract in total volume).
- microbiological tests such as Eosin Methylen Blue Agar, Blood Agar, Chocolate Agar, Saboraud-Dextrose Agar etc.
- the wound healing and burn cream with white tea extract can also be used so as to prevent wrinkles by increasing the number of collagen fibrils in the connective tissue with the ingredients therein.
- Epigallocatechin-3- gallate ameliorates erectile function in aged rats via regulation of PRMT1/DDAH/ADMA/NOS metabolism pathway. Asian Journal of Andrology, 18 (September 2015), 291-297.
- Dendritic cells modulate burn wound healing by enhancing early proliferation. Wound Repair and Regeneration, 24 (1), 6-13. Van Der Wal, M.B.A., Van Zuijlen, P.P., Van De Ven, P., and Middelkoop, E., 2010. Topical silicone gel versus placebo in promoting the maturation of burn scars: A randomized controlled trial. Plastic and Reconstructive Surgery, 126 (2), 524-531.
- TRPC1 deletion causes striatal neuronal cell apoptosis and proteomic alterations in mice.
- Urinary 8- OHdG a marker of oxidative stress to DNA and a risk factor for cancer, atherosclerosis and diabetics. Elsevier.
- p53 Is Involved in But Not Required for Ionizing Radiation-induced Caspase-3 Activation and Apoptosis in Human Lymphoblast Cell Lines Advances in Brief p53 Is Involved in But Not Required for Ionizing Radiation-induced Caspase-3 Activation and Apoptosis i, (617), 4277 ⁇ 281.
- Caspase-3 regulates the migration , invasion , and metastasis of colon cancer cells, (919), 1-26.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Birds (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Emergency Medicine (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention relates to a wound healing and burn cream containing Camellia sinensis (white tea) extract that helps healing of skin lesions, particularly burn lesions and wounds. Said cream increases the synthesis of collagen fibrils by supporting the epithelial cells in the skin, ensures healing of skin lesions after burns or physical damage by reducing apoptosis and suppressing the production of free oxygen radicals. In addition, the inventive cream prevents skin wrinkles by increasing the number of collagen fibrils.
Description
WOUND HEALING AND BURN CREAM WITH CAMELLIA SINENSIS (WHITE TEA)
ESSENTIAL
Field of the Invention
The present invention relates to a wound healing and burn cream containing Camellia sinensis (white tea) extract that helps healing of skin lesions, particularly burn lesions and wounds. Said cream increases the synthesis of collagen fibrils by supporting the epithelial cells in the skin, ensures healing of skin lesions after burns or physical damage by reducing apoptosis and suppressing the production of free oxygen radicals. In addition, the inventive cream prevents skin wrinkles by increasing the number of collagen fibrils.
State of the Art
Burn is a type of injury that results in losing the integrity of the skin due to high heat, extreme cold, electricity, friction, radiation or chemicals. Burns may occur due to many environmental factors. It may occur due to too much exposure to the sun, electric shocks, boiling water, fire or many other similar external factors. Today, most of the burns are caused by home accidents or the sun. Burns may occur in various forms such as; thermal burns (flame, steam burns), chemical burns (by contact with acid or base products), radiation burns (sun rays, tanning beds, etc.), electrical burns. Burn symptoms vary based on the severity of the burn. There may be peeling, skin discoloration and pain. The most common complication pertaining to burns is infection. Electricity burns cause compartment syndrome (edema in the area where the muscles gathered) and rhabdomyolysis (sudden and rapid damage to the muscle tissues in the body for any reason) due to damage to the muscles. It may cause a decrease in bone density and loss of muscle mass based on the degree of burn. The patient may experience stress disorder after trauma by being psychologically affected in major burns. There may be disturbing scars based on the degree and size of the burn. Sunburns may lead to skin cancer. Burns are evaluated in different severities as first, second and third degrees. Treatment is determined based on the degree of burn. The first and second degree burns heal within 2-3 weeks without leaving a scar with drug treatment. If more than 2/3 of the dermis are affected, scars and loss of function are seen. For this reason, it may require surgical intervention. Scar is formed and loss of function is seen and surgical intervention is required because the dermis and epidermis are completely burned in third degree burns. l
According to the data of the World Health Organization (WHO) in the year 2014, more than 10 million people all over the world apply to hospitals for treatment purposes and about 3% of them result in death due to burns (Nzioka et at. 2016). Although burn treatments vary according to the degree and types of burns, more than half of the patients who apply to clinics due to burns receive ambulatory care as dressing treatment, particularly topical creams (Mantle et al. 2001 , Arslan et al. 2012). The market share of skin protective and therapeutic creams in the world is 6.7 billion dollars annually, and this number has been increasing for the last decade (Nzioka et al. 2016). Anti-inflammatory zinc oxide, antibiotic; topical creams containing heavy metals such as bacitracin, silver sulfadiazine etc., various topical creams ensuring wound closure, corticosteroids, creams containing imiquimod and interferons are used within this scope (Arslan et al. 2012, Shpichka et al. 2019). In the state of the art, in the studies performed, Silicone layers, wound care silicone gel layers (Mantle et al. 2001 , Arslan et al. 2012, Shpichka et al. 2019), silastic gel layers (Arslan et al. 2012, Builders et al. 2013, Nzioka et al. 2016, Shpichka et al. 2019), different types of silicone have been used, such as Sil-K silicone (Lee et al. 1996, Van Der Wal et al. 2010). Moreover, epiderm silicone layers or silicone gel treatments have only been studied in various patient populations such as Europe, Afro-American, Chinese, Indians, Malays and Eurasia; however, the treatment mechanisms were not reported in detail (Salman and Ozdemir 2018). Treatment methods of silicone gel layers are generally applied for 12-24 hours a day, except bath time (Akyuz 2008, Baktir 2020). Topical silicone gel is applied twice a day. The compatibility of these treatments with other treatments (if any) and not recording daily hygiene is considered. Today, these existing treatment methods cover a period ranging from 12 to 28 weeks (Sari et al. n.d., etinkaya O. 2001, Akyuz 2008, KURT OZKAYA et al. 2014). In addition to this, today, there are studies that can be obtained completely from herbal extracts (Allium cepa, Aloe vera, Santalum album, Acer palmatum) (Zhu and Gao 2008, Lorenti 2012). It was stated that the treatment expected from these creams with organic plant extracts in skin burns and skin lesions increases the number of collagen and reticular fibrils under the skin and assists in increasing mitotic activity by protecting the stratum germinativum layer (productive layer) in the skin epithelium (Sari et al. n.d., Carney et al. 1994, etinkaya O. 2001, Akyuz 2008, Stallings and Lupo 2009, Lorenti 2012, Builders etal. 2013, KURT OZKAYA et al. 2014, Shpichka etal. 2019).
The skin is the largest organ of the human body responsible for the protection, temperature regulation and sensitivity of the organism and consists of three layers: epidermis, dermis and hypodermis. The epidermis is the outermost layer of the skin and consists mostly of cells that are called keratinocytes. The dermis is the second layer of skin under the epidermal layer. The main cells in the dermis are fibroblasts and constitute the extracellular support matrix
tissue of the dermis. Hypodermis is the lowest layer of the skin and consists of cells that are called lipocytes. In burn studies, although agents that have a direct effect on the epidermis are not known, there are many studies dealing with their effects on the dermis layer (Stallings and Lupo 2009, Builders et at. 2013, Anthonissen et al. 2016). Skin healing is a systemic process that comprises; hemostasis (coagulation), inflammation (mononuclear cell infiltration), proliferation (epithelization, fibroplasia, angiogenesis and granulation tissue formation) and maturation (collagen accumulation or tissue formation), respectively, in the wound area (Hermans 2005, Zhu and Gao 2008, Stallings and Lupo 2009, Lorenti 2012, Atat et al. 2015, Anthonissen et al. 2016, Shpichka et al. 2019). Each of these four systemic processes observed during the regeneration of the skin in skin burns vary based on various factors such as cause of the burn, its degree, size and general condition of the patient. The differences in the processes cause changes in the treatment of burns. The healing process may cause different results depending on the severity of the burn. Superficial burns heal within two weeks and cause minimal scarring. Re-epithelization of burns with partial thickness is provided by keratinocyte migration from the dermal extensions of the skin a few hours after the injury. In deeper burns; healing starts around the edges, but not in the center depending on the requirement of rapid wound closure (Sari et al. n.d., Stallings and Lupo 2009, Builders et al. 2013, KURT OZKAYA et al. 2014, Atat et al. 2015, Anthonissen et al. 2016, Shpichka et al. 2019, Baktir 2020). The acceleration of early cell proliferation that ensures quick recovery of burns is caused by dendritic cells that release various factors. Therefore, agents that increase dendritic cells are considered as therapeutics that improve burn-wound care (Vinish et al. 2016, Bae etal. 2017).
Today, studies are carried out so as to develop creams that are completely derived from plants organically to substitute the creams containing heavy metals such as topical zinc oxide and silver sulfadiazine used currently (Sari et al. n.d., etinkaya O. 2001, Hermans 2005, Akyuz 2008, Wolfram et al. 2009, Van Der Wal et al. 2010, Wasiak and Cleland 2015, Baktir 2020). The expected treatment of creams in skin lesions such as skin burns that are caused by contact with physical and chemical substances is to increase the number of collagen and reticular fibrils under the skin and to assist in skin healing with its positive effects on keratonocytes and dendritic cells in the skin epithelium (Hermans 2005, Li-Tsang et al. 2006, Sakallioglu et al. 2006, Wolfram et al. 2009, Zhang et al. 2010, Lorenti 2012, Degeorge et al. 2014, Wasiak and Cleland 2015, Vinish et al. 2016, Bae et al. 2017). It was reported that herbal flavonoids and catechins (EG), especially epigalactocatechin gallate (EGCG), have an important effect on increasing the number of collagen and reticular fibrils in the connective tissue under the skin in the studies performed within this scope (Huang et al. 2005, Lee et al. 2005, Jeong et al. 2007, Yoneyama et al. 2008, Domingo et al. 2010, Peairs
et al. 2010, Kim et al. 2013, Li et al. 2016). Although it was reported in previous studies that the epigalactocateechin is mostly found in green tea, it was reported that epigalactocatechins are found mostly in white tea in recent studies. In addition to this, white tea has a very rich content (Islam 2011 , Oyetakinwhite et al. 2012, Salman and Ozdemir 2018, Yildirim et al. 2020).
Angiogenesis is induced by hypoxia-induced factor 1 and angiogenic cytokines such as VEGF and CXCL12 during healing of the burn (Wilgus et al. 2008, Wolfram et al. 2009, Domingo et al. 2010, Zhang etal. 2010, Atat et al. 2015, Li et al. 2016, Shpichka et al. 2019). It was reported in recent studies that epigalactocatechin gallate (EGCG) has positive effects on dendritic cells in the epidermis layer (Jeong et al. 2007, Yoneyama et al. 2008). In addition to this, in the study of Hsu et al; it was shown that EGCG and flavonoids provide the growth of keratinocytes in the epidermis layer and reactivate dying old keratonocytes (Hsu et al. 2003). Cells that migrate towards the surface of the skin normally live for about 28 days and prepare to die basically in the upper layer of the skin until the 20th day (Hsu et al. 2003, Wilgus et al. 2008, Zhang et al. 2010, Lorenti 2012, Atat et al. 2015, Wasiak and Cleland 2015, Vinish et al. 2016, Shpichka et al. 2019, Baktir 2020). However, it was reported that epigalactocatechin gallate (EGCG), epigalactocatechin (EGC) and flavonoids activate keratonocytes in the findings. It was reported that the high amount of EGCG, catechins (EG) and flavonoids in white tea have very positive effects on keratonocytes and dendritic cells in the epidermis layer of the skin, and in addition to its properties rarely found in other protective agents, it also increases the number of collagen and reticular fibrils in the dermis and hypodermis layers of the skin (Hsu et al. 2003, Hsu 2005, Yoneyama et al. 2008, Li et al. 2016). Although it has been reported in previous studies that EGCG is mostly found in green tea, in the light of today's studies, it was reported that EGCG is mostly found in white tea, and again white tea was also shown to have a very rich content (Yoneyama et al. 2008, Islam 2011 , Oyetakinwhite et al. 2012, Kim et al. 2018, Salman and Ozdemir 2018, Yildirim etal. 2019a, Yildirim et al. 2020).
The inflammation after burn is one of the most important cellular events in the formation of cytotoxicity. Transcription factor plays a key role in the activation of genes encoding proinflammatory cytokines such as nuclear factor-kappa B (NFk-B), TNF-a and I L-1 b (Yang et al. 2014, Tsai et al. 2015, Espinosa et al. 2016). Multiple studies reported that inhibition of NF-KB transcriptional activity prevents the damage that occurs as a result of the inflammation after the burn (Yang et al. 2014, Dias et al. 2016, Espinosa et al. 2016). In addition, free oxygen radicals (SOR) formed in the skin after burns change DNA by structurally causing mutation (Bernatoniene and Kopustinskiene 2018, Cremonini et al. 2019). DNA damage and
SOR accumulation causes the activation of p53 or also known as tumor protein 53 (TP53) protein (Bernatoniene and Kopustinskiene 2018). Active p53 is a transcription factor that binds to DNA by forming tetramer. The most important task of p53 controlling many genes is to employ cell DNA damage repair mechanisms by slowing down the cell cycle. If the damage cannot be repaired, it directs the cell to apoptosis (Winiarska-Mieczan 2015, Bernatoniene and Kopustinskiene 2018, Cremonini et at. 2019). 8-hydroxy-2p- deoxyguanosine (8-OHdG) in nuclear and mitochondrial DNA induced by SOR is associated with oxidative lesions and therefore it is widely used as a biomarker for oxidative stress (Chen et al. 2016, Luk et al. 2020). Although other nucleobases of DNA react similar to SOR, the 8-OHdG lesion is the most voluminous DNA lesion. Since it is relatively easily formed and promutogenic, for this reason, it is a potential biomarker of carcinogenesis (Valavanidis et al. 2009, Kawahara et al. 2010, Wang et al. 2018). Studies have shown that 8-OHdG is a good biomarker for risk assessment of various cancers and degenerative diseases (Wu et al. n.d., Magura and Rozhmanova 1997, Kitada et al. 2001 , Valavanidis et al. 2009, Kawahara et al. 2010, Fardid et al. 2017, Christopher et al. 2020, Kundovic et al. 2020). Intrinsic apoptosis is a cell death centered in mitochondria caused by mitochondrial outer membrane permeabilization-mediated apoptosome formation, activation of caspase-9 and subsequent activation of effector caspases (Thornberry 1998, Yang et al. 1998, Reed 2000, Galluzzi et al. 2016). Activation of caspase-3 plays an extremely important role in apoptosis among applying caspases and is accepted as a terminal event prior to cell death. Bcl-2 (B-cell lymphoma 2) prevents the effects of Bax (BCL2-associated X protein), which is a proapoptotic protein by being located in the outer membrane of mitochondria, maintains mitochondrial membrane integrity and supports cell survival. On the other hand, Bax increases mitochondrial permeability by causing both cytochrome C and SOR to be discharged from the mitochondria to the cytoplasm under oxidative stress conditions. Cytochrome C forms an apoptosome that activates caspase-3, a key regulator in the execution of apoptosis by interacting with apoptotic proteactivation factor 1 (Apaf-1) in the cytoplasm (Zhou et al. n.d., Ohta et al. 1997, Yu and Little 1998, Snigdha et al. 2012, Brentnall et al. 2013, Lopez-Furelos et al. 2016). While many mechanisms play a role in the induction of apoptosis, the most well-known mechanism has effect on DNA synthesis and repair; it was reported that it involves in the formation of reactive oxygen radicals (SOR) and initiates apoptosis through intrinsic caspases, causing mitochondrial dysfunction and stress in the endoplasmic reticulum (Zhou et al. n.d., Ohta et al. 1997, Porter and Janicke 1999, Snigdha et al. 2012, Brentnall et al. 2013). In studies, it was reported that SOR triggers the redox sensitive transcription factor nuclear factor kappa-B (NF-KB) (Romano et al. 1999, Pande and Ramos 2005, Murley etal. 2006, Lawrence 2009).
Although the tissue damage mechanism varies depending on the types of burns, it was reported in the studies that increases the level of malondialdehyde (MDA) by causing lipid peroxidation and decreases the amount of antioxidant enzymes, mainly glutathione (GSH), and decreases glutathione peroxidase activity (GSH-Px), causing oxidative stress by increasing the production of free oxygen radicals (Hermans 2005, Momeni et al. 2009, Zhang et al. 2010, Lorenti 2012, Atat et al. 2015, Anthonissen et al. 2016, Bae et al. 2017, Shpichka et al. 2019, Baktir 2020). Besides, it was reported that pro-inflammatory cytokines, which play a role in inflammation in SOR tissues, increase the expression of the biomarker NF- Kb/r65 (Hermans 2005, Sakallioglu et al. 2006, Momeni et al. 2009, Zhang et al. 2010, Lorenti 2012, Builders et al. 2013, Atat et al. 2015, Anthonissen et al. 2016, Bae et al. 2017, Shpichka et al. 2019, Baktir 2020). At the same time, it was also reported that it induces apoptosis in cells due to the increase of SOR in tissues (Stallings and Lupo 2009, Wolfram et al. 2009, Arslan et al. 2012, Lorenti 2012, Shpichka et al. 2019). It was reported in studies that white tea (Camellia sinensis), which contains EGC, which is known as one of the most powerful free oxygen scavengers due to the richest number of hydroxyl groups of all teas suppresses oxidative stress by blocking the production of SOR (Almajano et al. 2008, Espinosa et al. 2014, 2016, 2016, Dias et al. 2016, Salman and Ozdemir 2018, Saral et al. 2019a, 2019b, Ylldlrlm etal. 2020).
In brief, inflammation, oxidative stress and mitochondrial dysfunction together with increasing tissue damage have an important role in the etiology of skin burns. It was mentioned in the previous data that green tea catechins prevent tissue damage by reducing inflammatory signaling mediators and upregulating anabolic mediators. Moreover, it was mentioned that green tea catechins serves for ensuring a dynamic balance between protein synthesis and degradation and increasing the synthesis of mitochondrial energy metabolism and alleviate the effects of aging. On the other hand, in a study performed by Dong Chen et al., it was set forth that EGCG contributes to the development of collagen fibrils.
In the state of the art, in addition to dressing of skin burns, costly treatment approaches such as surgical debridement, escarectomy, fasciotomy, severe fluid resuscitation, grafting, synthetic temporary closures are applied depending on the type of burn observed on the skin (1 , 2 or 3 degrees) and tissue depth. Complex treatments that are applied in addition to these treatments lead to workload on healthcare professionals, and cause losses in ergonomics of patients in their daily lives.
It is required to develop a novel wound-burn cream due to reasons such as the inadequacy of the treatments applied in wound and burn treatments in the state of the art, the existing
wound-burn creams being effective only on the connective tissue, not providing an effective healing, and not having reliable ingredients.
Brief Description of the Invention and Aims of the Invention
The present invention describes a wound healing and burn cream containing white tea ("Camellia sinensis"), which has a protective effect on tissue damage. While said cream heals skin lesions after burns or physical damage, it also prevents skin wrinkles by increasing the number of collagen fibrils.
An aim of the invention is to develop a wound and burn cream that provides effective healing. The inventive cream provides an effective treatment for skin tissue damage and especially in the treatment of burns due to its healing effect on the epidermis in addition to the connective tissue.
Another aim of the invention is to provide a wound healing and burn cream that does not have a negative effect on the human health due to its natural content. The white tea extract contained in the content of the invention provides a protective effect on tissue damage formed as a result of burn. It does not cause any side effects, not only it is a natural ingredient, but also it provides an environmentally friendly content.
Another aim of the invention is to provide a cream with an anti-wrinkle formulation besides preventing skin lesions. Said wound and burn cream also has an anti-wrinkle effect in addition to healing wounds and burns. This effect is ensured by increasing the number of collagen fibrils in the connective tissue of the ingredients in the cream.
Another aim of the invention is to develop a cost efficient method for wound and burn treatment. As a result of using the wound and burn cream provided with the invention, the treatment of skin tissue damage is effectively provided, it reduces treatment costs by replacing burn intensive care and skin transplantation, which is a troublesome and expensive method.
The inventive wound healing and burn cream;
- Supports epithelial cells by strengthening the connection between skin epithelial cells, Increases the number of cells (stratum germinativum) in the reproductive layer of the skin epithelium,
Increases the synthesis of collagen and reticular fibrils in the subcutaneous connective tissue and thus the number of collagen and reticular fibrils,
Induces interferon-gamma (IFN-y) secretion by acting on dendritic cells, Reduces apoptosis in epithelial cells in the skin,
- Shows the effect of reducing the production of free oxygen radicals. Detailed Description of the Invention
The present invention is a wound healing and burn cream that increases the synthesis of collagen fibrils by supporting the epithelial cells in the skin, ensures healing of skin lesions after burns or physical damage by reducing apoptosis and suppressing the production of free oxygen radicals. Cream with white tea extract contains; white tea ( Camellia sinensis) extract, saturated fatty acids, monosaturated and polyunsaturated fatty acids, vitamin E and paraffin.
Said wound healing and burn cream contains the following; 8-12% of white tea extract by weight, 8-12% of saturated fatty acids by weight, 32-36% of monounsaturated fatty acids by weight, 3-7% of polyunsaturated fatty acids by weight, 3-7% of vitamin E by weight and 33- 37% of paraffin by weight. In a preferred embodiment of the invention, said wound healing and burn cream contains the following; 10.14% of white tea extract, by weight 10.48% of saturated fatty acids by weight, 34% of monounsaturated fatty acids by weight, 5.38% of polyunsaturated fatty acids by weight, 5% of vitamin E by weight and 35% of paraffin by weight (Table 1). The white tea extract used in said cream contains 35-39% of polyphenol by weight, preferably 37.05% of polyphenol in total, but no cellulose. The white tea extract used in the country is preferably used as catechin contains; 2.89% of gallic acid by weight, 0.96% of catechin (C) by weight, 5.31% of epicatechin (EC) by weight, 74.61% of epigallocatechin gallate (EGCG) by weight and 16.23% of epicatechin gallate (ECG) by weight (Table 2). This white tea extract also contains; 0.064 ppm copper (Cu), 0.112 ppm iron (Fe), 0.65 ppm zinc (Zn), 2.47 ppm sodium (Na), 492 ppm potassium (K), 14.51 ppm calcium (Ca), 311 ppm manganese (Mn), 69.3 ppm magnesium (Mg,), 1.59 ppm aluminum (Al) (Table 3).
Table 1. Content analysis of wound healing and burn cream ( 100 mg by weight).
10
The polyphenols, saturated fatty acids, monounsaturated fatty acids, polyunsaturated fatty acids and vitamin E contained in the cream have the effect of reducing free oxygen radicals by reducing the apoptosis in the epithelial cells of the skin. The iron, copper and manganese contained in white tea extract increase the number of collagen and reticular fibrils in the subcutaneous connective tissue. The aluminum content included in the ingredient exhibits an antiseptic effect; while zinc has an antiseptic effect, it also strengthens the connection between skin epithelial cells. Paraffin content also provides an antiseptic effect to the cream.
Said cream contains 2-3% catechin in total. Catechins are natural antioxidants that assist in preventing the cell damage. Catechin can reduce the formation of free radicals in the body and protect cells and molecules against radical damage. It is known that free radicals play a role in accelerating the aging process. EGCG (Epigallocatechin Gallate) is one of the most powerful compounds found in "green tea". EGCG and EGC from these catechins from white tea extract increase the number of the productive layer (stratum germinativum) in the skin epithelium, increase the number of collagen and reticular fibrils in subcutaneous connective tissue, inhibits the antigen presenting mechanism of dendritic cells. At the same time, these catechins have the effect of reducing free oxygen radicals by reducing apoptosis in epithelial cells in the skin.
In the present invention; the most suitable extract was obtained by analyzing the brewed, dried, wet extracts and their catechin groups and mineral contents by HPLC analysis (Tables
1-4) so as to examine the protective and therapeutic effects of white tea extract against physiological aging or physical and chemical trauma, skin clinical correlations due to skin burns.
Burn cream prototype is obtained with its ingredients by mixing the obtained extract, white tea extract previously obtained with natural methods with the cream that is previously designed and contains alkali esters (72%), free fatty acids (14%), hydrocarbons (11%), free alcohols (1%), oleic acid, paraffin, stearic acid, vitamin E and neutral saturated fat (with a ratio of 3% white tea extract in total volume).
For the cream formulation obtained in the invention; - various HPLC, mineral, catechin groups (such as EC, EGC, EGCG ...) and flavonoids and other chemical analysis,
- microbiological tests (such as Eosin Methylen Blue Agar, Blood Agar, Chocolate Agar, Saboraud-Dextrose Agar etc.)
- tests regarding the determination of the correct packaging technology to increase the shelf life of the product and determination of preservatives based on the selected packaging type (antifungal, bacteriocitatic agents), were carried out.
The wound healing and burn cream with white tea extract can also be used so as to prevent wrinkles by increasing the number of collagen fibrils in the connective tissue with the ingredients therein.
REFERENCES
Akyuz, N., 2008. YARA BAKIMI ve TEDAVISI. Yara Bakimi ve Tedavisi.
Almajano, M.P., Carbo, R., Jimenez, J.A.L., and Gordon, M.H., 2008. Antioxidant and antimicrobial activities of tea infusions. Food Chemistry, 108 (1), 55-63.
Anthonissen, M., Daly, D., Janssens, T., and Van Den Kerckhove, E., 2016. The effects of conservative treatments on burn scars: A systematic review. Bums, 42 (3), 508-518.
Arslan, K., Karahan, O., Okus, A., Unlu, Y., Eryilmaz, M.A., Ay, S., and Sevinc, B., 2012. Comparison of topical zinc oxide and silver sulfadiazine in burn wounds: an experimental study. Turkish Journal of Trauma and Emergency Surgery, 18 (5), 376- 383.
Atat, D.F., Supplement, U., Kodu, M., and Tarihi, K., 2015. YUMU§AK DOKUDA YARA iYil_E§MESi, ETKILEYEN FAKTORLER VE SKAR REVIZYONU SOFT TISSUE WOUND HEALING, EFFECTING FACTORS AND SCAR REVISION Ar§. Gor. Dt. Humeyra YAZAR *, 152-161.
Bae, L., Bohannon, J.K., Cui, W., Vinish, M., and Toliver-Kinsky, T., 2017. Fms-like tyrosine kinase-3 ligand increases resistance to burn wound infection through effects on plasmacytoid dendritic cells. BMC Immunology, 18 (1), 1-9.
Baktir, G., 2020. Wound Repair and Experimental Wound Models. Experimed, 9 (3), ISO- 137.
Bernatoniene, J. and Kopustinskiene, D.M., 2018. The Role of Catechins in Cellular Responses to Oxidative Stress. Molecules, 23 (4), 1-11.
Brentnall, M., Rodriguez-menocal, L., Guevara, R.L. De, Cepero, E., and Boise, L.H., 2013. Caspase-9 , caspase-3 and caspase-7 have distinct roles during intrinsic apoptosis. BMC Cell Biology, 14 (1), 1.
Builders, P., Kabele-Toge, B., Builders, M., Chindo, B., Anwunobi, P., and Isimi, Y., 2013. Wound Healing Potential of Formulated Extract from Hibiscus Sabdariffa Calyx. Indian Journal of Pharmaceutical Sciences, 75 (1), 45.
Carney, S.A., Cason, C.G., Gowar, J.P., Stevenson, J.H., McNee, J., Groves, A.R., Thomas, S.S., Hart, N.B., and Auclair, P., 1994. Cica-care gel sheeting in the management of hypertrophic scarring. Burns, 20 (2), 163-167. etinkaya O., 2001. Yamk Yarasi ve Tedavisi. 1.0. Cerrahpafla T>p Fakdltesi Surekli Tip
Egitimi Etkinlikleri Cilt Hastahklan ve Vara Bakimi Sempozyumu, 89-103.
Chen, D., Zhang, K.Q., Li, B., Sun, D.Q., Zhang, H., and Fu, Q., 2016. Epigallocatechin-3- gallate ameliorates erectile function in aged rats via regulation of PRMT1/DDAH/ADMA/NOS metabolism pathway. Asian Journal of Andrology, 18 (September 2015), 291-297.
Christopher, P.W., Wedierpass Elisabete, and Bernard, W.S., 2020. World cancer report 2020. World Health Organization. Lyon: International Agency for Research on Cancer 2020 Some.
Cremonini, E., Fraga, C.G., and Oteiza, P.I., 2019. (-)-Epicatechin in the control of glucose homeostasis: Involvement of red ox -regulated mechanisms. Free Radical Biology and Medicine, 130 (November 2018), 478^88.
Degeorge, B.R., Rodeheaver, G.T., and Drake, D.B., 2014. The biophysical characteristics of human composite flexor tendon allograft for upper extremity reconstruction. Annals of Plastic Surgery, 72 (SUPPL. 2).
Dias, T.R., Alves, M.G., Rato, L., Casal, S., Silva, B.M., and Oliveira, P.F., 2016. White tea intake prevents prediabetes-induced metabolic dysfunctions in testis and epididymis preserving sperm quality. Journal of Nutritional Biochemistry, 37, 83-93.
Domingo, D.S., Camouse, M.M., Hsia, A.H., Matsui, M., Maes, D., Nicole, L., Cooper, K.D., and Baron, E.D., 2010. Anti-angiogenic effects of EGCG, 3 (7).
Espinosa, C., Lopez-Jimenez, J.A., Perez-Llamas, F., Guardiola, F.A., Esteban, M.A., Arnao, M.B., and Zamora, S., 2016. Long-term intake of white tea prevents oxidative damage caused by adriamycin in kidney of rats. Journal of the Science of Food and Agriculture, 96 (9), 3079-3087.
Espinosa, C., Perez-Llamas, F., Guardiola, F.A., Esteban, M.A., Arnao, M.B., Zamora, S., and Lopez-Jimenez, J.A., 2014. Molecular mechanisms by which white tea prevents oxidative stress. Journal of Physiology and Biochemistry, 70 (4), 891-900.
Fardid, R., Salajegheh, A., Mosleh-Shirazi, M.A., Sharifzadeh, S., Okhovat, M.A., Najafi, M., Rezaeyan, A., and Abaszadeh, A., 2017. Melatonin ameliorates the production of COX- 2, iNOS, and the formation of 8-OHdG in non-targeted lung tissue after pelvic irradiation. Cell Journal, 19 (2), 324-331.
Galluzzi, L., Lopez-Soto, A., Kumar, S., and Kroemer, G., 2016. Caspases Connect Cell- Death Signaling to Organismal Homeostasis. Immunity, 44 (2), 221-231 .
Hermans, M.H.E., 2005. A general overview of burn care. International Wound Journal, 2 (3).
Hsu, S., 2005. Green Tea Linked To Skin Cell Rejuvenation [online]. Medical College Of Georgia. Available from: https://www.sciencedaily.com/releases/2003/04/030425071800.htm [Accessed 13 Mar 2020]
Hsu, S., Bollag, W.B., Lewis, J., Huang, Q., Singh, B., Sharawy, M., Yamamoto, T., and Schuster, G., 2003. Green tea polyphenols induce differentiation and proliferation in epidermal keratinocytes. Journal of Pharmacology and Experimental Therapeutics, 306 (1), 29-34.
Huang, C.C., Fang, J.Y., Wu, W. Bin, Chiang, H.S., Wei, Y.J., and Hung, C.F., 2005. Protective effects of (-)-epicatechin-3-gallate on UVA-induced damage in HaCaT keratinocytes. Archives of Dermatological Research, 296 (10), 473-481.
Islam, M.S., 2011. Effects of the aqueous extract of white tea (Camellia sinensis) in a streptozotocin-induced diabetes model of rats. Phytomedicine, 19 (1), 25-31 .
Jeong, Y. II, Jung, I.D., Lee, J.S., Lee, C.M., Lee, J.D., and Park, Y.M., 2007. (-)- Epigallocatechin gallate suppresses indoleamine 2,3-dioxygenase expression in murine dendritic cells: Evidences for the COX-2 and STAT1 as potential targets. Biochemical and Biophysical Research Communications, 354 (4), 1004-1009.
Kawahara, A., Azuma, K., Hattori, S., Nakashima, K., Basaki, Y., Akiba, J., Takamori, S., Aizawa, H., Yanagawa, T., Izumi, H., Kohno, K., Kono, S., Kage, M., Kuwano, M., and Ono, M., 2010. The close correlation between 8-hydroxy-2???-deoxyguanosine and epidermal growth factor receptor activating mutation in non-small cell lung cancer. Human Pathology, 41 (7), 951-959.9.
Kim, E., Hwang, K., Lee, J., Han, S.Y., Kim, E.M., Park, J., and Cho, J.Y., 2018. Skin protective effect of epigallocatechin gallate. International Journal of Molecular Sciences, 19 (1), 1-14.
Kim, J.E., Shin, M.H., and Chung, J.H., 2013. Epigallocatechin-3-gallate prevents heat shock-induced MMP-1 expression by inhibiting AP-1 activity in human dermal fibroblasts. Archives of Dermatological Research, 305 (7), 595-602.
Kitada, T., Seki, S., Iwai, S., Yamada, T., Sakaguchi, H., and Wakasa, K., 2001. In situ detection of oxidative DNA damage, 8-hydroxydeoxyguanosine, in chronic human liver disease. Journal of Hepatology, 35 (5), 613-618.
Kundovic, S.A., Rasic, D., Popovic, L, Peraica, M., and Rnjar, K., 2020. Oxidative stress under general intravenous and inhalation anaesthesia. Arhiv za Higijenu Rada I Toksikologiju, 71 (3), 169-177.
KURT OZKAYA, N., ALGAN, S., and AKKAYA, H., 2014. Yanikli Hastanin Degerlendirilmesi ve Tedavi Yakla§iminin Belirlenmesi. Ankara Medical Journal, 14 (4), 170-175.
Lawrence, T., 2009. The nuclear factor NF-kappaB pathway in inflammation. Cold Spring Harbor perspectives in biology, 1 (6), 1-10.
Lee, J.H., Chung, J.H., and Cho, K.H., 2005. The effects of epigallocatechin-3-gallate on extracellular matrix metabolism. Journal of Dermatological Science, 40 (3), 195-204.
Lee, S.M., Ngim, C.K., Chan, Y.Y., and Ho, M.J., 1996. A comparison of Sil-K and Epiderm in scar management. Burns, 22 (6), 483^87.
Li-Tsang, C.W.P., Lau, J.C.M., Choi, J., Chan, C.C.C., and Jianan, L., 2006. A prospective randomized clinical trial to investigate the effect of silicone gel sheeting (Cica-Care) on post-traumatic hypertrophic scar among the Chinese population. Burns, 32 (6), 678- 683.
Li, M., Xu, J., Shi, T., Yu, H., Bi, J., and Chen, G., 2016. Epigallocatechin-3-gallate augments therapeutic effects of mesenchymal stem cells in skin wound healing. Clinical and Experimental Pharmacology and Physiology, 43 (11 ), 1115-1124.
Lopez-Furelos, A., Leiro-Vidal, J.M., Salas-Sanchez, A. A., Ares-Pena, F.J., and Lopez- Martin, M.E., 2016. Evidence of cellular stress and caspase-3 resulting from a combined two-frequency signal in the cerebrum and cerebellum of sprague-dawley rats. Oncotarget, 7 (40).
Lorenti, A., 2012. Wound Healing: From Epidermis Culture to Tissue Engineering. CellBio, 01 (02), 17-29.
Luk, H.Y., Appell, C., Chyu, M.C., Chen, C.H., Wang, C.Y., Yang, R. Sen, and Shen, C.L., 2020. Impacts of green tea on joint and skeletal muscle health: Prospects of translational nutrition. Antioxidants, 9 (11), 1-28.
Magura, I.S. and Rozhmanova, O.M., 1997. Oxidative stress and neurodegenerative disorders. Biopolymers and Cell, 13 (6), 513-515.
Mantle, D., Gok, M., and Lennard, T., 2001. Adverse and beneficial effects of plant extracts on skin and skin disorders. Adverse Drug Reactions and Toxicological Reviews, 20 (2), 89-103.
Momeni, M., Hafezi, F., Rahbar, H., and Karimi, H., 2009. Effects of silicone gel on burn scars. Bums, 35 (1), 70-74.
Murley, J.S., Kataoka, Y., Weydert, C.J., Oberley, L.W., and Grdina, D.J., 2006. Delayed radioprotection by nuclear transcription factor kappaB -mediated induction of manganese superoxide dismutase in human microvascular endothelial cells after exposure to the free radical scavenger WR1065. Free radical biology & medicine, 40 (6), 1004-1016.
Nzioka, A.M., Kim, M.G., Hwang, H.U., Yan, C.Z., Ved, V.E., Meshalkin, V.P., and Kim, Y.J., 2016. Experimental investigation on the drying of loosely-packed and heterogeneous municipal solid waste. Theoretical Foundations of Chemical Engineering, 50 (4), 414- 421.
Ohta, T., Kinoshita, T., Nozaki, T., Masutani, M., Tsuruo, T., and Miyajima, A., 1997. CELL BIOLOGY AND METABOLISM : Requirement of the Caspase-3 / CPP32 Protease Cascade for Apoptotic Death following Cytokine Deprivation in Requirement of the Caspase-3 / CPP32 Protease Cascade for Apoptotic Death following Cytokine Deprivation in Hematopoi, 272 (37), 23111-23116.
Oyetakinwhite, P., Tribout, H., and Baron, E., 2012. Protective mechanisms of green tea polyphenols in skin. Oxidative Medicine and Cellular Longevity, 2012.
Pande, V. and Ramos, M.J., 2005. Molecular recognition of 15-deoxy-A12, 14-prostaglandin J2by nuclear factor-kappa B and other cellular proteins. Bioorganic and Medicinal Chemistry Letters, 15 (18), 4057-4063.
Peairs, A., Dai, R., Gan, L., Shimp, S., Rylander, M.N., Li, L., and Reilly, C.M., 2010. Epigallocatechin-3-gallate (EGCG) attenuates inflammation in MRL/lpr mouse mesangial cells. Cellular and Molecular Immunology, 7 (2), 123-132.
Porter, A.G. and Janicke, R.U., 1999. Emerging roles of caspase-3 in apoptosis. Cell Death and Differentiation, 6 (2), 99-104.
Reed, J.C., 2000. Mechanisms of Apoptosis. The American Journal of Pathology, 157 (5), 1415-1430.
Romano, M.F., Lamberti, A., Bisogni, R., Garbi, C., Pagnano, A.M., Auletta, P., Tassone, P., Turco, M.C., and Venuta, S., 1999. Amifostine inhibits hematopoietic progenitor cell apoptosis by activating NF-kappaB/Rel transcription factors. Blood, 94 (12), 4060-4066.
Sakallioglu, A.E., Ba§aran, O., Ozdemir, B.H., Arat, Z., Yucel, M., and Haberal, M., 2006.
Local and systemic interactions related to serum transforming growth factor-b levels in burn wounds of various depths. Bums, 32 (8), 980-985.
Salman, S. and Ozdemir, F., 2018. Beyaz ay: Oretimi, Bile§imi ve Saglik Ozerine Etkileri. Akademik Gida, 16 (2), 218-223.
Saral, S., Dokumacioglu, E., Mercantepe, T., Atak, M., Cinar, S., Saral, O., Yildiz, L., Iskender, H., and Tumkaya, L., 2019a. The effect of white tea on serum TNF-a/NF-kB and immunohistochemical parameters in cisplatin-related renal dysfunction in female rats. Biomedicine and Pharmacotherapy, 112 (January), 108604.
Saral, S., Dokumacioglu, E., Mercantepe, T., Atak, M., Cinar, S., Saral, O., Yildiz, L., Iskender, H., and Tumkaya, L., 2019b. The effect of white tea on serum TNF-a/NF-kB and immunohistochemical parameters in cisplatin-related renal dysfunction in female rats. Biomedicine and Pharmacotherapy.
Sari, O., Onar, T., and Aydogan, 0., n.d. Birinci basamakta yara ve yamk bakimi Wound and burn management in primary care, 53-58.
Shpichka, A., Butnaru, D., Bezrukov, E.A., Sukhanov, R.B., Atala, A., Burdukovskii, V., Zhang, Y., and Timashev, P., 2019. Skin tissue regeneration for burn injury. Stem Cell Research & Therapy, 10 (1), 1-16.
Snigdha, S., Smith, E.D., Prieto, G.A., and Cotman, C.W., 2012. Caspase-3 activation as a bifurcation point between plasticity and cell death. Neuroscience Bulletin, 28 (1), 14-24.
Stallings, A.F. and Lupo, M.P., 2009. Practical uses of botanicals in skin care. Journal of Clinical and Aesthetic Dermatology, 2 (1), 36-40.
Thornberry, N.A., 1998. Caspases: Enemies Within. Science, 281 (5381), 1312-1316.
Tsai, M.-S., Chien, C.-C., Lin, T.-H., Liu, C.-C., Liu, R.H., Su, H.-L., Chiu, Y.-T., and Wang, S.-H., 2015. Galangin Prevents Acute Hepatorenal Toxicity in Novel Propacetamol- Induced Acetaminophen-Overdosed Mice. Journal of medicinal food, 18 (11), 1187-97.
Valavanidis, A., Vlachogianni, T., and Fiotakis, C., 2009. 8-Hydroxy-2' -deoxyguanosine (8- OHdG): A critical biomarker of oxidative stress and carcinogenesis. Journal of Environmental Science and Health - Part C Environmental Carcinogenesis and Ecotoxicology Reviews, 27 (2), 120-139.
Vinish, M., Cui, W., Stafford, E., Bae, L., Hawkins, H., Cox, R., and Toliver-Kinsky, T., 2016. Dendritic cells modulate burn wound healing by enhancing early proliferation. Wound Repair and Regeneration, 24 (1), 6-13.
Van Der Wal, M.B.A., Van Zuijlen, P.P., Van De Ven, P., and Middelkoop, E., 2010. Topical silicone gel versus placebo in promoting the maturation of burn scars: A randomized controlled trial. Plastic and Reconstructive Surgery, 126 (2), 524-531.
Wang, D., Yu, H., Xu, B., Xu, H., Zhang, Z., Ren, X., Yuan, J., Liu, J., Guo, Y., Spencer, P.S., and Yang, X., 2018. TRPC1 deletion causes striatal neuronal cell apoptosis and proteomic alterations in mice. Frontiers in Aging Neuroscience, 10 (MAR), 1-11.
Wasiak, J. and Cleland, H., 2015. Burns : dressings Search date January 2014 Burns : dressings, (January 2014), 1-44.
Wilgus, T.A., Ferreira, A.M., Oberyszyn, T.M., Bergdall, V.K., and DiPietro, L.A., 2008. Regulation of scar formation by vascular endothelial growth factor. Laboratory Investigation, 88 (6), 579-590.
Winiarska-Mieczan, A., 2015. The potential protective effect of green, black, red and white tea infusions against adverse effect of cadmium and lead during chronic exposure - A rat model study. Regulatory Toxicology and Pharmacology, 73 (2), 521-529.
Wolfram, D., Tzankov, A., RϊiIzI, P., and Piza-Katzer, H., 2009. Hypertrophic scars and keloids - A review of their pathophysiology, risk factors, and therapeutic management. Dermatologic Surgery, 35 (2), 171-181.
Wu, L., Chiou, C., Chang, P., acta, J.W.-C. chimica, and 2004, undefined, n.d. Urinary 8- OHdG: a marker of oxidative stress to DNA and a risk factor for cancer, atherosclerosis and diabetics. Elsevier.
Yang, X., Stennicke, H.R., Wang, B., Green, D.R., Janicke, R.U., Srinivasan, A., Seth, P., Salvesen, G.S., and Froelich, C.J., 1998. Granzyme B Mimics Apical Caspases. Journal of Biological Chemistry, 273 (51), 34278-34283.
Yang, Y., Liu, H., Liu, F., and Dong, Z., 2014. Mitochondrial dysregulation and protection in cisplatin nephrotoxicity. Archives of Toxicology, 88 (6), 1249-1256.
Ylldlrlm, M., Saral, S., Mercantepe, T., iskender, H., Tumkaya, L., Atak, M., and Ta§gl, F., 2020. White Tea Reduced Bone Loss by Suppressing the TRAP/CTX Pathway in Ovariectomy- Induced Osteoporosis Model Rats. Cells Tissues Organs.
Yoneyama, S., Kawai, K., Tsuno, N.H., Okaji, Y., Asakage, M., Tsuchiya, T., Yamada, J., Sunami, E., Osada, T., Kitayama, J., Takahashi, K., and Nagawa, H., 2008. Epigallocatechin gallate affects human dendritic cell differentiation and maturation. Journal of Allergy and Clinical Immunology, 121 (1), 209-214.
Yu, Y. and Little, J.B., 1998. p53 Is Involved in But Not Required for Ionizing Radiation- induced Caspase-3 Activation and Apoptosis in Human Lymphoblast Cell Lines Advances in Brief p53 Is Involved in But Not Required for Ionizing Radiation-induced Caspase-3 Activation and Apoptosis i, (617), 4277^281. Zhang, X., Liu, L., Wei, X., Tan, Y.S., Tong, L., Chang, R., Ghanamah, M.S., Reinblatt, M., Marti, G.P., Harmon, J.W., and Semenza, G.L., 2010. Impaired angiogenesis and mobilization of circulating angiogenic cells in HIF-1a heterozygous-null mice after burn wounding. Wound Repair and Regeneration, 18 (2), 193-201.
Zhou, M., Liu, X., Li, Z., Huang, Q., Li, F., and Li, C., n.d. Caspase-3 regulates the migration , invasion , and metastasis of colon cancer cells, (919), 1-26.
Zhu, W. and Gao, J., 2008. The use of botanical extracts as topical skin-lightening agents for the improvement of skin pigmentation disorders. Journal of Investigative Dermatology Symposium Proceedings, 13 (1), 20-24.
Claims
1. A wound healing and burn cream that increases the synthesis of collagen fibrils by supporting the epithelial cells in the skin, ensures healing of skin lesions after burns or physical damage by reducing apoptosis and suppresses the production of free oxygen radicals, characterized in that, it comprises; 8-12% of white tea (Camellia sinensis) extract, 8-12% of saturated fatty acids by weight, 32-36% of monounsaturated fatty acids by weight, 3-7% of polyunsaturated fatty acids by weight, 3-7% of vitamin E by weight and 33-37% of paraffin by weight.
2. A cream according to claim 1 , characterized in that; it contains 10.14% of white tea extract by weight, 10.48% of saturated fatty acids by weight, 34% of monounsaturated fatty acids by weight, 5.38% of polyunsaturated fatty acids by weight, 5% of vitamin E by weight and 35% of paraffin by weight.
3. A cream according to claim 1 , characterized in that; the white tea extract contains 37.05% of polyphenol by weight in total.
4. A cream according to claim 1 , characterized in that; the white tea extract comprises the following as catechin; contains 2.89% of gallic acid by weight, 0.96% of catechin (C) by weight, 5.31% of epicatechin (EC) by weight, 74.61% of epigallocatechin gallate (EGCG) by weight and 16.23% of epicatechin gallate (ECG) by weight.
5. A cream according to claim 1 , characterized in that; white tea extract contains; 0.064 ppm copper (Cu), 0.112 ppm iron (Fe), 0.65 ppm zinc (Zn), 2.47 ppm sodium (Na), 492 ppm potassium (K), 14.51 ppm calcium (Ca), 311 ppm manganese (Mn), 69.3 ppm magnesium (Mg,), 1.59 ppm aluminum (Al).
6. A cream according to any of the preceding claims, characterized in that; it contains white tea extract with anti-wrinkle effect.
7. A cream to be used for preventing wrinkles characterized by comprising the following; 8-12% of white tea (Camellia sinensis) extract, 8-12% of saturated fatty acids by weight, 32-36% of monounsaturated fatty acids by weight, 3-7% of polyunsaturated fatty acids by weight, 3-7% of vitamin E by weight and 33-37% of paraffin by weight.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TR2021/00058A TR202100058A1 (en) | 2021-01-05 | 2021-01-05 | CAMELLIA SINENSIS (WHITE TEA) ESSENTIAL WOUND AND BURN CREAM |
TR2021/00058 | 2021-01-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2022150023A1 true WO2022150023A1 (en) | 2022-07-14 |
Family
ID=82357532
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/TR2021/050457 WO2022150023A1 (en) | 2021-01-05 | 2021-05-11 | Wound healing and burn cream with camellia sinensis (white tea) essential |
Country Status (2)
Country | Link |
---|---|
TR (1) | TR202100058A1 (en) |
WO (1) | WO2022150023A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115006317A (en) * | 2022-07-27 | 2022-09-06 | 水羊化妆品制造有限公司 | Method for enriching fuding white tea flavone by using natural eutectic solvent and application |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996000584A1 (en) * | 1994-06-30 | 1996-01-11 | Warner-Lambert Company | Anti-inflammatory wound healing compositions and methods for preparing and using same |
-
2021
- 2021-01-05 TR TR2021/00058A patent/TR202100058A1/en unknown
- 2021-05-11 WO PCT/TR2021/050457 patent/WO2022150023A1/en active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996000584A1 (en) * | 1994-06-30 | 1996-01-11 | Warner-Lambert Company | Anti-inflammatory wound healing compositions and methods for preparing and using same |
Non-Patent Citations (2)
Title |
---|
AKBULUT A ET AL.: "Mineral Içerikleri, Antioksidan ve Antimikrobiyal Aktivite Yönünden Karsilastirilmasi", AKADEMIK ZIRAAT DERGISI, vol. 9, no. 2, 24 September 2020 (2020-09-24), pages 279 - 288, DOI: 10.29278/azd.720699 * |
HAJIAGHAALIPOUR F ET AL.: "The Effect of Camellia sinensis on Wound Healing Potential in an Animal Model", EVID BASED COMPLEMENT ALTERNAT MED, vol. 2013, 20 June 2013 (2013-06-20), pages 386734, XP055957652, DOI: 10.1155/2013/386734 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115006317A (en) * | 2022-07-27 | 2022-09-06 | 水羊化妆品制造有限公司 | Method for enriching fuding white tea flavone by using natural eutectic solvent and application |
Also Published As
Publication number | Publication date |
---|---|
TR202100058A1 (en) | 2022-05-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Koca et al. | Wound repair potential of Olea europaea L. leaf extracts revealed by in vivo experimental models and comparative evaluation of the extracts' antioxidant activity | |
Bahri et al. | Relevance of carnosic acid to the treatment of several health disorders: Molecular targets and mechanisms | |
Askari et al. | Evaluation of the effects of Iranian propolis on the severity of post operational-induced peritoneal adhesion in rats | |
Medellín-Luna et al. | Medicinal plant extracts and their use as wound closure inducing agents | |
Mehta et al. | The evidence for natural therapeutics as potential anti-scarring agents in burn-related scarring | |
Zhang et al. | The efficacy of sodium aescinate on cutaneous wound healing in diabetic rats | |
Yang et al. | Research progress on therapeutic effect and mechanism of propolis on wound healing | |
Georgescu et al. | Natural compounds for wound healing | |
Ramamurthy et al. | Phytochemical, pharmacological and toxicological properties of Ficus deltoidea: a review of a recent research | |
Namchaiw et al. | The leaf extract of Coccinia grandis (L.) Voigt accelerated in vitro wound healing by reducing oxidative stress injury | |
Al-Waili et al. | Propolis and bee venom in diabetic wounds; a potential approach that warrants clinical investigation | |
Liu et al. | The potential application of natural products in cutaneous wound healing: A review of preclinical evidence | |
Lulseged et al. | Wound healing and antioxidant properties of 80% methanol leaf extract of Verbascum sinaiticum (scrophulariaceae): an Ethiopian medicinal plant | |
WO2022150023A1 (en) | Wound healing and burn cream with camellia sinensis (white tea) essential | |
CN108852924A (en) | Chenopodium quinoa extract with antiaging, skin whitening, antiallergic and cell repairing effects | |
Gupta et al. | Healing Potential of Propolis Extract–Passiflora edulis Seed Oil Emulgel Against Excisional Wound: Biochemical, Histopathological, and Cytokines Level Evidence | |
Manginstar et al. | Therapeutic potential of propolis in alleviating inflammatory response and promoting wound healing in skin burn | |
Hassanpour et al. | Pathophysiological effects of sulfur mustard on skin and its current treatments: possible application of phytochemicals | |
Soni et al. | Novel modalities of delivering herbal medicines for wound healing: a review | |
Kavousi et al. | Wound healing effects and related mechanisms of action of methanol extracts of Boswellia sacra and Commiphora myrrha oleo-gum-resins on adult human dermal fibroblasts (HDFa) | |
Alasbahi et al. | Evaluation of the wound healing activity of twelve herbal and non-herbal remedies used in Sana’a-Yemen for the treatment of wounds and burns | |
Niknam et al. | In vivo evaluation of wound healing properties of Platanus orientalis L. | |
Kim et al. | A literature review of bioactive substances for the treatment of periodontitis: In vitro, in vivo and clinical studies | |
CN109276493A (en) | Longan flower extract with anti-aging, whitening, anti-allergic and cell repairing functions | |
Kuria | Efficacy of aspilia pluriseta schweinf in cutaneous wound healing in a mouse model |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 21916660 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 21916660 Country of ref document: EP Kind code of ref document: A1 |